본문 바로가기

Data Plus(+)

All 807,818 Page 37,446/80,782

검색

Contents

No Journal_name Subject Date DOI Author
433368 BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE SUMO protease SENP1 acts as a ceRNA for TGFBR2 and thus activates TGFBR2/Smad signaling responsible for LPS-induced sepsis 2019-04-01 10.1016/j.biopha.2019.108620 Zhang Chao, Li Jing, Qiu Xiaosong, Chen Yuzhu, Zhang Xin
433367 BMJ OPEN Tailored digital behaviour change intervention with e-referral system to increase attendance at NHS stop smoking services (the MyWay project): study protocol for a randomised controlled feasibility trial 2019-04-01 10.1136/bmjopen-2018-028721 Fulton Emily, Newby Katie, Gokal Kajal, Kwah Kayleigh, Schumacher Lauren, Jackson Louise J, Naughton Felix, Coleman Tim, Brown Katherine
433366 DOSE-RESPONSE A PUBLICATION OF INTERNATIONAL HORMESIS SOCIETY An RNA-seq-Based Expression Profiling of Radiation-Induced Esophageal Injury in a Rat Model 2019-04-01 10.1177/1559325819843373 Sun Zhiqiang, Li Jinhui, Lin Min, Zhang Shuyu, Luo Judong, Tang Yiting
433365 HYPOXIA Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model 2019-04-01 10.2147/hp.s196301 Yakkundi Poonam, Gonsalves Eleanor, Galou-Lameyer Maria, Selby Mark, Chan William
433364 NEURO-ONCOLOGY DIPG-38. DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO 2019-04-01 10.1093/neuonc/noz036.059 Steino Anne, Yang Xiaodong, Kline Cassie, Brown Dennis, Bacha Jeff, Liu Lei, Mueller Sabine
433363 NEURO-ONCOLOGY TMOD-02. CHARACTERIZATION OF THE TUMOR IMMUNE MICROENVIRONMENT IN A PEDIATRIC HIGH GRADE GLIOMA MOUSE MODEL HARBORING THE H3.3-G34R MUTATION 2019-04-01 10.1093/neuonc/noz036.241 Fabiani Maria Garcia, Haase Santiago, Kadiyala Padma, Alghamri Mahmoud, Comba Andrea, Nuñez Felipe, Whalen Matthew, Lowenstein Pedro, Castro Maria
433362 RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY EP-1905 CT /PET based dosiomics and radiomics model predicts local control of nasopharyngeal carcinoma 2019-04-01 10.1016/s0167-8140(19)32325-4 Avanzo M., Pirrone G., Avigo C., Fanetti G., Stancanello J., De Paoli A., Elisa P., Drigo A., Chiovati P., Dassie A., Borsatti E., Baresic T., Franchin G., Sartor G.
433361 RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY EP-2080 MC simulations on the dose enhancement effect of antibody conjugated AuNPs in targeted radiotherapy 2019-04-01 10.1016/s0167-8140(19)32500-9 Klapproth A., Li W., Stangl S., Diederichs C., Shevtsov M., Ntziachristos V., Multhoff G.
433360 RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY EP-1770 Investigation of Electronic Portal Imaging Based In-Vivo Dose Verification for Prostate SBRT 2019-04-01 10.1016/s0167-8140(19)32190-5 Biltekin F., Yedekci F.Y., Ozyigit G.
433359 RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY EP-1769 Pre-treatment VMAT verification with SunCHECK Fraction 0 and Varian Portal Dosimetry – a comparison 2019-04-01 10.1016/s0167-8140(19)32189-9 Hoven N.I., Kalsnes J., Lønne P.